|
|
影像学对乳腺癌新辅助化疗疗效评价的研究进展
|
Abstract:
在2020年的全球肿瘤流行病统计数据(GLOBOCAN)报告中，女性乳腺癌已经超过肺癌，成为最常见的诊断癌症。研究表明，乳腺癌新辅助化疗(Neoadjuvant chemotherapy, NAC)可有效增加外科手术乳腺的保存率，提高病变的控制率和综合生存率，而对于评价乳腺癌新辅助化疗疗效，影像学在其中起了重要作用。本文主要阐述不同影像技术对于乳腺癌新辅助化疗后疗效评价的现状及进展作一综述。
In the 2020 Global Cancer Epidemic Statistics (GLOBOCAN) report, female breast cancer has ex-ceeded lung cancer and become the most common diagnostic cancer. Studies have shown that neo-adjuvant chemotherapy (NAC) for breast cancer can effectively increase the survival rate of surgical breast, improve the control rate of lesions and the overall survival rate, and imaging plays an im-portant role in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer. This article reviews the current status and progress of different imaging techniques in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer.
| [1] | Sung, H., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660 |
| [2] | 林志琴, 曾澄, 等. 乳腺癌新辅助化疗及预后的相关研究[J]. 赣南医学院学报, 2022, 42(3): 265-269. |
| [3] | Therasse, P., et al. (2000) New Guidelines to Evaluate the Response to Treatment in Solid Tumors. Journal of the National Cancer Institute, 92, 205-216. https://doi.org/10.1093/jnci/92.18.1534 |
| [4] | Litière, S., et al. (2017) RECIST—Learning from the Past to Build the Future. Nature Reviews. Clinical Oncology, 14, 187-192. https://doi.org/10.1038/nrclinonc.2016.195 |
| [5] | Thomassin-Naggara, I., et al. (2014) Standardized Diagnosis and Reporting of Breast Cancer. Diagnostic and Interventional Imaging, 95, 759-766. https://doi.org/10.1016/j.diii.2014.06.006 |
| [6] | Fowler, A.M., et al. (2017) Imaging Neoadjuvant Therapy Response in Breast Cancer. Radiology, 285, 358-375.
https://doi.org/10.1148/radiol.2017170180 |
| [7] | Kim, Y.-S., et al. (2016) Residual Mammographic Microcalcifica-tions and Enhancing Lesions on MRI after Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size. Annals of Surgical Oncology, 23, 1135-1142. https://doi.org/10.1245/s10434-015-4993-2 |
| [8] | Kratkiewicz, K., et al. (2022) Ultrasound and Photoacoustic Im-aging of Breast Cancer: Clinical Systems, Challenges, and Future Outlook. Journal of Clinical Medicine, 11, 1165. https://doi.org/10.3390/jcm11051165 |
| [9] | Evans, A., et al. (2018) Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy for Primary Breast Cancer Comparing Interim Ultrasound, Shear Wave Elastography and MRI. Ultraschall in der Medizin, 39, 422-431.
https://doi.org/10.1055/a-0797-4532 |
| [10] | Pujji, O., et al. (2020) How Accurate Is Ultrasound Scan in Predicting the Size of Residual Breast Cancer Following Neoadjuvant Chemotherapy? European Journal of Surgical Oncology, 46, E58.
https://doi.org/10.1016/j.ejso.2019.11.121 |
| [11] | Wang, J., et al. (2021) A Narrative Review of Ultrasound Tech-nologies for the Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer. Cancer Management and Re-search, 13, 7885-7895.
https://doi.org/10.2147/CMAR.S331665 |
| [12] | Han, X., et al. (2021) Application of Conventional Ultrasonography Combined with Contrast-Enhanced Ultrasonography in the Axillary Lymph Nodes and Evaluation of the Efficacy of Ne-oadjuvant Chemotherapy in Breast Cancer Patients. The British Journal of Radiology, 94, Article ID: 20210520. https://doi.org/10.1259/bjr.20210520 |
| [13] | Mattingly, A.E., et al. (2016) Magnetic Resonance Imaging for Axillary Breast Cancer Metastasis in the Neoadjuvant Setting: A Prospective Study. Clinical Breast Cancer, 17, 180-187. https://doi.org/10.1016/j.clbc.2016.11.004 |
| [14] | Radhika, R., et al. (2004) Change in Tumor Cellularity of Breast Carcinoma after Neoadjuvant Chemotherapy as a Variable in the Pathologic Assessment of Response. Cancer, 100, 1365-1373. https://doi.org/10.1002/cncr.20134 |
| [15] | Baumgartner, A., et al. (2018) Ultrasound-Based Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients. Breast (Edinburgh, Scotland), 39, 19-23. https://doi.org/10.1016/j.breast.2018.02.028 |
| [16] | Marinovich, M.L., et al. (2015) Accuracy of Ultrasound for Pre-dicting Pathologic Response during Neoadjuvant Therapy for Breast Cancer. International Journal of Cancer, 136, 2730-2737. https://doi.org/10.1002/ijc.29323 |
| [17] | 徐民, 纪建松, 卢陈英, 陈述政, 王祖飞. 多层螺旋CT对进展期乳腺癌新辅助化疗的疗效评估[J]. 医学影像学杂志, 2012, 22(10): 1677-1680. |
| [18] | 陈文哲, 蒋博. 双能低剂量能谱CT曲线斜率评估乳腺癌新辅助化疗疗效的价值初探[J]. 影像研究与医学应用, 2020, 4(22): 44-47. |
| [19] | Abedi, M., et al. (2013) The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemo-therapy in Locally Advanced Breast Cancer. International Journal of Cancer Management, 6, 28-35. |
| [20] | Choi, W.J., et al. (2019) Comparison of Pathologic Response Evaluation Systems after Neoadjuvant Chemotherapy in Breast Cancers: Correlation with Computer-Aided Diagnosis of MRI Features. AJR. American Journal of Roentgenology, 213, 944-952. https://doi.org/10.2214/AJR.18.21016 |
| [21] | Tayda？, O., et al. (2019) Comparison of MRI and US in Tumor Size Evaluation of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. European Journal of Breast Health, 15, 119-124. https://doi.org/10.5152/ejbh.2019.4547 |
| [22] | Goorts, B., et al. (2018) MRI-Based Response Patterns dur-ing Neoadjuvant Chemotherapy Can Predict Pathological (Complete) Response in Patients with Breast Cancer. Breast Cancer Research: BCR, 20, Article No. 34.
https://doi.org/10.1186/s13058-018-0950-x |
| [23] | 王艾博, 边杰. DCE-MRI原理及临床应用情况[J]. 中国临床医学影像杂志, 2016, 27(6): 435-438. |
| [24] | Adina, C. and Adina, C. (2017) Indications of the Magnetic Resonance Method in Breast Pathology. Chirurgia, 112, 367-377. https://doi.org/10.21614/chirurgia.112.4.367 |
| [25] | Valdora, F., Houssami, N., Rossi, F., et al. (2018) Rapid Review: Radiomics and Breast Cancer. Breast Cancer Research and Treatment, 169, 217-229. https://doi.org/10.1007/s10549-018-4675-4 |
| [26] | 赵林, 何翠菊, 陈莉, 等. 动态增强MRI和扩散加权成像在乳腺癌新辅助化疗早期预测疗效的价值[J]. 中国肿瘤, 2010, 19(5): 351-354. |
| [27] | Lima, Z.S., et al. (2019) Application of Imaging Technologies in Breast Cancer Detection: A Review Article. Open Access Macedonian Journal of Medical Sciences, 7, 838-848. https://doi.org/10.3889/oamjms.2019.171 |
| [28] | Radhakrishna, S., Agarwal, S., Parikh, P., et al. (2018) Role of Magnetic Resonance Imaging in Breast Cancer Management. The South Asian Journal of Cancer, 7, 69-71. |
| [29] | Sheling, M., et al. (2000) Positron Emission Tomography Using [(18)F]Fluorodeoxyglucose for Monitor-ing Primary Chemotherapy in Breast Cancer. Journal of Clinical Oncology, 18, 1689-1695.
https://doi.org/10.1200/JCO.2000.18.8.1689 |
| [30] | Smith, I.C., Welch, A.E., Hutcheon, A.W., Mille, I.D., Payne, S., et al. (2000) Positron Emission Tomography Using [18F]-Fluorodeoxy-d-glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy. Journal of Clinical Oncology, 18, 1676-1688. https://doi.org/10.1200/JCO.2000.18.8.1676 |
| [31] | Wahl, R.L., Zasadny, K., Helvie, M., et al. (1993) Metabolic Monitoring of Breast Cancer Chemohormonotherapy Using Positron Emission Tomography: Initial Evaluation. Journal of Clinical Oncology, 11, 2101-2111.
https://doi.org/10.1200/JCO.1993.11.11.2101 |
| [32] | Groheux, D., Hindie, E., Rubello, D., et al. (2009) Should FDG PET/CT Be Used for the Initial Staging of Breast Cancer? European Journal of Nuclear Medicine and Molecular Imag-ing, 36, 1539-1542.
https://doi.org/10.1007/s00259-009-1159-0 |
| [33] | Caresia Aroztegui, A.P., et al. (2017) 18F-FDG PET/CT in Breast Cancer: Evidence-Based Recommendations in Initial Staging. Tumour Biology, 39, 1-23. https://doi.org/10.1177/1010428317728285 |
